Clinical Trials
119 trialsINDIGO
Boston Scientific Corporation
China Metastatic Liver Cancer Clinical Registry Cohort Database
Anhui Provincial Hospital
RE-BALANCE
National Cancer Centre, Singapore
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Anhui Provincial Hospital
Extracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
Kirros
Genentech, Inc.
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Alnylam Pharmaceuticals
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
Incyte Corporation
ROWAN
Boston Scientific Corporation
GRACE
Duke University
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
ABK Biomedical
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
M.D. Anderson Cancer Center
Liver Cancer Prevention Randomized Control Trial
M.D. Anderson Cancer Center
LivMOD
Institut National de la Santé Et de la Recherche Médicale, France
Breath Analysis Based Disease Biomarkers
Mayo Clinic
Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
Celgene
DETECT
University Hospital Muenster
Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation
Istanbul Medipol University Hospital
LIVERMET-IRE
Angiodynamics, Inc.
FAST (Focused Abbreviated Screening Technique)-MRI Study
Icahn School of Medicine at Mount Sinai
A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment
Bristol-Myers Squibb
AB-LATE02
University Hospital, Montpellier
LIVER-TRACK
Assistance Publique - HĂ´pitaux de Paris
Liver Disease and Other Systemic Diseases
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System
University of Texas Southwestern Medical Center
TRIABETES
University of Pittsburgh
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)
National Cancer Centre, Singapore
LSM
Assistance Publique - HĂ´pitaux de Paris
Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions
Rigshospitalet, Denmark
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
Bristol-Myers Squibb
Feasibility Analysis of LCD-SLA 3D Printing Technology for Overall Surgical Planning of Liver Malignant Tumors
Affiliated Hospital of Hebei University
Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)
ABK Biomedical
Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration
McGill University Health Centre/Research Institute of the McGill University Health Centre
REGAL
Sheikh Shakhbout Medical City
bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC
Sun Yat-sen University
Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction
National University Hospital, Singapore
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
Taiho Oncology, Inc.
A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems
Takeda
OPTIMA
Imunon
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
Sun Yat-sen University
PRO-NRG
Academisch Ziekenhuis Maastricht
Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction
Astex Pharmaceuticals, Inc.
HEPATIC
Helio Genomics
HMCV
University Hospital, Strasbourg, France
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
Sichuan Cancer Hospital and Research Institute
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Blueprint Medicines Corporation
Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma
Sun Yat-sen University
MWA
Wake Forest University Health Sciences